(Q51506548)

6 April 2018

title

Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. (English)

1 reference

6 April 2018

1 reference

2

Jim van Os

1 reference

6 April 2018

Jeroen Decoster

1

1 reference

6 April 2018

Gunter Kenis

3

1 reference

6 April 2018

Cecile Henquet

4

1 reference

6 April 2018

Joseph Peuskens

5

1 reference

6 April 2018

Marc De Hert

6

1 reference

6 April 2018

Ruud van Winkel

7

1 reference

6 April 2018

publication date

8 February 2011

1 reference

6 April 2018

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

published in

1 reference

6 April 2018

volume

156B

1 reference

6 April 2018

page(s)

363-369

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

Gender differences in age at onset of schizophrenia. An overview

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

BDNF Val66Met variant and age of onset in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cannabis use and misuse prevalence among people with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

First-episode schizophrenia: I. Early course parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Clinical characteristics influencing age at onset in psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

No association between MTHFR C677T or A1298C and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Spurious genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cannabis use and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Regional brain abnormalities associated with long-term heavy cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

Cannabis use and age of diagnosis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31174

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.31174

1 reference

6 April 2018

PubMed ID

21305693

1 reference

6 April 2018